Zenotech Laboratories share news and announcements

BSE: 532039Pharmaceuticals & BiotechnologySmall Cap

₹40.31₹0.81 (2.05%)

Share price at the BSE close on 23 Oct 2026. Previous close ₹39.50.

52-week range of traded prices to 23 Oct 2026

₹33.55Low, 30 Mar 2026₹54.14High, 31 Oct 2025

Next results date: the board meets on 28 Oct 2026 to consider: quarterly results.

Market cap: ₹246 Cr2,190th largest listed
P/E: Lossover the last 12 months
P/B: 2.6
Dividend yield: Nonein the last 12 months
ROE: −2.6%
ROCE: −3.9%
Debt to equity: 0.00
Volume, BSE: 3,902

Zenotech Laboratories share news and announcements

494 announcements, routine notices left out, newest first. Page 3 of 10.

Feb 2023
- 1 Feb · Intimation Pursuant To Regulation 31A Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 ('SEBI Listing Regulations')
  With reference to the above, we wish to inform you that the Stock Exchange i.e. BSE Limited has approved the reclassification of Daiichi Sankyo Company Limited from 'Promoter' to 'Public' .... (opens in a new tab)
Jan 2023
- 27 Jan · Announcement under Regulation 30 (LODR)-Meeting Updates
  With reference to the intimation of Board Meeting submitted on January 19, 2023, we wish to inform you that the Meeting of the Board of Directors of the Company was held today i.e. January .... (opens in a new tab)
- 27 Jan · Results
  With reference to the intimation of Board Meeting submitted on January 19, 2023, we wish to inform you that the Meeting of the Board of Directors of the Company was held today i.e. January .... (opens in a new tab)
- 19 Jan · Board meeting
  Meeting on 27 Jan 2023: quarterly results
- 19 Jan · Board meeting
  ZENOTECH LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/01/2023 ,inter alia, to consider and approve the Unaudited Standalone .... (opens in a new tab)
Dec 2022
- 7 Dec · Legal
  We hereby confirm that we are in compliance with the requirements of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and the Company has not .... (opens in a new tab)
Nov 2022
- 16 Nov · Disclosure Of Related Party Transactions Of Zenotech Laboratories Limited (The Company) For The Half Year Ended September 30, 2022
  Disclosure of related party transactions for the half year .... (opens in a new tab)
Oct 2022
- 28 Oct · Announcement under Regulation 30 (LODR)-Meeting Updates
  With reference to the intimation of Board Meeting submitted on October 20, 2022, we wish to inform you that the Meeting of the Board of Directors of the Company was held today i.e. October .... (opens in a new tab)
- 28 Oct · Results
  With reference to the intimation of Board Meeting submitted on October 20, 2022, we wish to inform you that the Meeting of the Board of Directors of the Company was held today i.e. October .... (opens in a new tab)
- 20 Oct · Board meeting
  Meeting on 28 Oct 2022: quarterly results
- 20 Oct · Statement Of Investor Complaints For The Quarter Ended September 2022
  No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 2 2 0
- 20 Oct · Board meeting
  ZENOTECH LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/10/2022 ,inter alia, to consider and approve the Unaudited Standalone .... (opens in a new tab)
Sep 2022
Aug 2022
Jul 2022
- 22 Jul · Board meeting
  Board of Directors of the Company at its meeting held today i.e. Friday, July 22, 2022 has inter alia considered and approved the Unaudited Standalone Financial Results of the Company .... (opens in a new tab)
- 22 Jul · Results
  Board of Directors of the Company at its meeting held today i.e. Friday, July 22, 2022 has inter alia considered and approved the Unaudited Standalone Financial Results of the Company .... (opens in a new tab)
- 14 Jul · Board meeting
  Meeting on 22 Jul 2022: quarterly results
- 14 Jul · Board meeting
  ZENOTECH LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/07/2022 ,inter alia, to consider and approve inter-alia, the Unaudited .... (opens in a new tab)
- 7 Jul · Statement Of Investor Complaints For The Quarter Ended June 2022
  No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 1 1 0
- 5 Jul · Intimation Pursuant To Regulation 31A Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
  We wish to inform you that the Company has submitted an application with your office today i.e., on July 05, 2022, seeking your approval for the reclassification of Daiichi Sankyo Company .... (opens in a new tab)
Jun 2022
- 22 Jun · Results
  Details of Voting results of Postal Ballot, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly <a href="https://www.bseindia.com/stock-share-price/meetings/voting-results/532039 ....
- 22 Jun · Results
  This is in reference to our Letter dated May 20, 2022 enclosing therein Notice of Postal Ballot dated April 29, 2022 seeking approval of Members of the Company, through remote e-voting .... (opens in a new tab)
- 15 Jun · Intimation Under Regulation 23(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Half Year Ended March 31, 2022
  Disclosure of Related Party Transactions of the Company .... (opens in a new tab)
May 2022
- 20 May · Meeting
  As per letter attached (opens in a new tab)
Apr 2022
- 29 Apr · Intimation Pursuant To Regulation 31A Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
  We would like to inform that Board of Directors of Zenotech Laboratories Limited (the Company) in their meeting held today i.e. on April 29, 2022 have considered and approved the request .... (opens in a new tab)
- 29 Apr · Results
  We enclose herewith the following: 1) the Standalone Audited .... (opens in a new tab)
- 29 Apr · Compliance Under Regulation 40(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Financial Year Ended March 31, 2022
  With reference to the subject, please find enclosed herewith the Certificate issued by Mr. Mahadev Tirunagari, Company Secretary in Practice, Hyderabad, in terms of regulation cited above .... (opens in a new tab)
- 22 Apr · Board meeting
  Meeting on 29 Apr 2022: audited results
- 22 Apr · Board meeting
  ZENOTECH LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/04/2022 ,inter alia, to consider and approve the Audited Standalone .... (opens in a new tab)
- 12 Apr · Statement Of Investor Complaints For The Quarter Ended March 2022
  No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
- 12 Apr · Compliance Certificate Pursuant To Regulation 7 (3) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015, As Amended - For The Financial Year Ended On March 31, 2022
  As per the requirement of Regulation 7(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby confirm that all activities pertaining to both physical .... (opens in a new tab)
Mar 2022
- 31 Mar · Intimation Pursuant To Regulation 31A Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
  This is to inform you that Daiichi Sankyo Company Limited, one of the Promoter of Zenotech Laboratories Limited (the Company) vide its letter dated March 31, 2022 has requested for reclassifying .... (opens in a new tab)
- 30 Mar · Disclosure
  Exchange has received the disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sun Pharmaceutical Industries Ltd (opens in a new tab)
- 30 Mar · Disclosure
  Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sun Pharmaceutical Industries Ltd (opens in a new tab)
- 29 Mar · Intimation Of Disclosure Of Inter-Se Transfer Of Shares Between Promoters
  As per attached letter (opens in a new tab)
- 29 Mar · Disclosure
  Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sun Pharmaceutical Industries Ltd (opens in a new tab)
- 22 Mar · Business
  Exchange has received the disclosure under Regulation 10(5) in respect of acquisition under Regulation 10(1)(a) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, .... (opens in a new tab)
Jan 2022
- 28 Jan · Results
  We wish to inform you that the Board .... (opens in a new tab)
- 18 Jan · Board meeting
  Meeting on 28 Jan 2022: quarterly results
- 18 Jan · Board meeting
  ZENOTECH LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/01/2022 ,inter alia, to consider and approve the Unaudited Standalone .... (opens in a new tab)
- 8 Jan · Shareholding for the Period Ended December 31, 2021
  Shareholding Pattern for the Period Ended December 31, 2021. For more details, kindly Click ....
- 8 Jan · Statement Of Investor Complaints For The Quarter Ended December 2021
  No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 1 1 0
Oct 2021
- 22 Oct · Results
  We wish to inform you that the Board .... (opens in a new tab)
- 14 Oct · Board meeting
  Meeting on 22 Oct 2021: quarterly results
- 14 Oct · Board meeting
  ZENOTECH LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/10/2021 ,inter alia, to consider and approve the Unaudited Standalone .... (opens in a new tab)

Zenotech Laboratories share news and announcements

Feb 2023

Jan 2023

Dec 2022

Nov 2022

Oct 2022

Sep 2022

Aug 2022

Jul 2022

Jun 2022

May 2022

Apr 2022

Mar 2022

Jan 2022

Oct 2021